STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Clarivate Launches AI-powered Regulatory Assistant Within Cortellis Suite to Boost Productivity and Ease Regulatory Burden

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
AI

Clarivate (NYSE:CLVT) has announced the beta launch of its AI-powered Regulatory Assistant within the Cortellis Regulatory Intelligence platform. The new tool, set for full release in September, aims to help regulatory professionals in biopharma, medtech, and research organizations navigate complex global requirements more efficiently.

The AI Assistant features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. The solution has been developed with input from industry partners, including Moderna, and builds on Clarivate's 30+ years of regulatory expertise and proven AI platform that powers other solutions like Web of Science.

Loading...
Loading translation...

Positive

  • Integration of AI technology to streamline regulatory compliance workflows
  • Partnership with major industry players like Moderna for beta testing
  • Built on established Clarivate AI platform with 30+ years of regulatory expertise

Negative

  • None.

Insights

Clarivate's new AI Regulatory Assistant strengthens its competitive position in life sciences intelligence, potentially boosting recurring revenue from subscription upgrades.

Clarivate's beta launch of an AI-powered Regulatory Assistant within its Cortellis Regulatory Intelligence platform represents a strategic enhancement to one of its core product offerings. The timing is particularly relevant as regulatory teams across pharma and medtech face increasing complexity in global compliance requirements. This AI capability directly addresses significant pain points in regulatory workflows - specifically the time-consuming process of searching through vast regulatory databases and interpreting complex requirements.

The product incorporates several valuable capabilities that differentiate it in the market: conversational AI with referenced answers, persistent conversation history, and multilingual support. These features align with enterprise demands for more efficient regulatory intelligence tools. Importantly, the solution is built on Clarivate's existing AI infrastructure that powers other products like Web of Science, suggesting efficient R&D resource allocation rather than building from scratch.

Endorsement from Moderna, a high-profile customer, provides external validation and indicates potential market reception. The September full release timeline suggests confidence in the technology's readiness. For Clarivate's business model, which relies heavily on recurring subscription revenue, this enhancement could strengthen customer retention while potentially enabling premium pricing or upselling opportunities for the enhanced Cortellis platform. This aligns with the broader industry trend of embedding AI capabilities into enterprise software to improve stickiness and justify subscription increases.

Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease

LONDON, Aug. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the beta launch of its AI-powered Regulatory Assistant within Cortellis Regulatory Intelligence. This new capability is designed to help regulatory professionals navigate complex and evolving global requirements with greater ease, speed and confidence. Informed by customer input and tested with industry partners, the beta version of the Regulatory Assistant is built to meet the real-world needs of regulatory professionals across biopharma, medtech and research organizations. The Regulatory Assistant will be launched to all Cortellis Regulatory Intelligence users in September with additional capabilities designed to further enhance usability, personalization and decision support.

Features within the Beta version of Cortellis Regulatory Intelligence AI Assistant include:

  • Conversational AI with referenced answers: Users can ask regulatory questions naturally and get precise, cited responses, saving hours of manual work. The AI-powered Assistant, guided by domain expertise, understands regulatory nuances to provide customers with accurate answers.
  • Your conversations, always within reach: Users can pick up right where they left off with chat history, resulting in more relevant, personalized responses.
  • Multilingual by design: Search and interact in preferred languages for a seamless, tailored experience.

Yuval Kiselstein, VP, R&D, Life Sciences & Healthcare at Clarivate, said: "Today's regulatory environment is increasingly complex and fast-changing. The beta launch of the Regulatory Assistant is a key milestone in our mission to empower regulatory teams with intuitive, AI-driven tools that enhance productivity and support confident, compliant decision-making. By working closely with our Collaborative Partners, we are building a solution that reflects real-world workflows and priorities."

Janeen Skutnik-Wilkinson, Director, Regulatory Intelligence & External Engagement, Moderna, said: "We are so pleased to be a part of the beta testing for the new AI Regulatory assistant. This tool will save us significant time and resources compared to searching manually, and we are already seeing how this will speed up internal enquiries and intelligence work. We have been impressed with how the team is actively engaging clients in the development process by seeking out and acting upon our feedback to continually improve the product. They are dedicated to building a useful tool that meets our needs while ensuring that it is also accurate and user-friendly."

With market-leading intelligence solutions, transformative data technologies and trusted AI, Clarivate equips customers with the insight and foresight they need across every stage of the product lifecycle, from early discovery through commercialization and beyond. In line with this commitment, the new AI-powered Regulatory Assistant brings the Clarivate mission to life by helping customers navigate complexity, accelerate decision-making and shape the future of healthcare.

As regulatory professionals face mounting pressure to keep pace with global changes, interpret complex requirements, and ensure compliance, the Regulatory Assistant streamlines access to trusted intelligence, enabling faster, more confident decisions. Built on the same proven Clarivate AI platform that powers Clarivate solutions, including Web of Science, and trusted by hundreds of organizations, it combines powerful technology with 30+ years of regulatory expertise relied on by top pharma and global agencies.

To learn more about the Cortellis Regulatory Intelligence AI-powered Regulatory Assistant, visit here.

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare.  For more information, please visit clarivate.com 

Media Contact:

Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
Clarivate
newsroom@clarivate.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-launches-ai-powered-regulatory-assistant-within-cortellis-suite-to-boost-productivity-and-ease-regulatory-burden-302529012.html

SOURCE Clarivate Plc

FAQ

What is Clarivate's new AI-powered Regulatory Assistant and when will it be available?

Clarivate's AI-powered Regulatory Assistant is a tool within Cortellis Regulatory Intelligence that helps regulatory professionals navigate global requirements. It's currently in beta and will be fully launched in September 2025.

What are the key features of Clarivate's new AI Regulatory Assistant?

The key features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. It provides precise, cited responses to regulatory questions.

How does Clarivate's AI Regulatory Assistant benefit pharmaceutical companies?

The AI Assistant helps regulatory teams save significant time and resources by providing quick access to regulatory information, streamlining internal inquiries, and supporting confident, compliant decision-making.

Who is involved in testing Clarivate's new AI Regulatory Assistant?

Moderna is among the beta testing partners, with their Director of Regulatory Intelligence confirming improved efficiency in handling internal inquiries and intelligence work.

What technology powers Clarivate's AI Regulatory Assistant?

The Assistant is built on the same proven Clarivate AI platform that powers Web of Science, combining advanced technology with over 30 years of regulatory expertise.
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Latest News

CLVT Latest SEC Filings

CLVT Stock Data

2.49B
341.16M
16.66%
89.99%
5.72%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United Kingdom
ST. HELIER